GAP Supply Act

This bill changes federal drug law for outsourcing facilities, which are businesses that compound (custom-make) drugs. Under current law, these facilities may compound certain drugs only if the drug is on the federal drug shortage list at the time they compound or distribute it. The bill would let them continue if the drug appeared on the shortage list within the past 180 calendar days. This gives facilities a period to keep supplying a drug after it comes off the shortage list.

Full text and official record on Congress.gov

Sponsors

• Earl L. "Buddy" Carter Republican sponsor
• 0 cosponsors